Natixis’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.1M | Buy |
+61,715
| New | +$11.2M | 0.06% | 229 |
|
|
2026
Q1 | – | Sell |
-139,018
| Closed | -$24.1M | – | 1248 |
|
|
2025
Q4 | $24.1M | Buy |
+139,018
| New | +$22.9M | 0.09% | 181 |
|
|
2025
Q3 | – | Sell |
-12,952
| Closed | -$3.86M | – | 1166 |
|
|
2025
Q2 | $3.86M | Buy |
12,952
+12,610
| +3,687% | +$3.96M | 0.02% | 388 |
|
|
2025
Q1 | $112K | Buy |
+342
| New | +$103K | ﹤0.01% | 787 |
|
|
2024
Q4 | – | Sell |
-1,379
| Closed | -$475K | – | 1136 |
|
|
2024
Q3 | $475K | Sell |
1,379
-21,434
| -94% | -$7.07M | ﹤0.01% | 648 |
|
|
2024
Q2 | $6.78M | Buy |
+22,813
| New | +$7.74M | 0.04% | 256 |
|
|
2024
Q1 | – | Sell |
-4,569
| Closed | -$1.65M | – | 1145 |
|
|
2023
Q4 | $1.65M | Buy |
4,569
+876
| +24% | +$309K | 0.01% | 440 |
|
|
2023
Q3 | $1.21M | Sell |
3,693
-71,997
| -95% | -$22.7M | 0.01% | 472 |
|
|
2023
Q2 | $22.8M | Buy |
75,690
+60,052
| +384% | +$17.3M | 0.19% | 114 |
|
|
2023
Q1 | $4.18M | Sell |
15,638
-30,246
| -66% | -$8.69M | 0.04% | 299 |
|
|
2022
Q4 | $15.2M | Buy |
45,884
+22,966
| +100% | +$7.8M | 0.09% | 210 |
|
|
2022
Q3 | $7.56M | Buy |
22,918
+20,368
| +799% | +$6.56M | 0.04% | 316 |
|
|
2022
Q2 | $713K | Sell |
2,550
-16,462
| -87% | -$4.97M | ﹤0.01% | 889 |
|
|
2022
Q1 | $6.34M | Buy |
19,012
+18,157
| +2,124% | +$5.59M | 0.02% | 501 |
|
|
2021
Q4 | $272K | Sell |
855
-151
| -15% | -$44.9K | ﹤0.01% | 1138 |
|
|
2021
Q3 | $273K | Sell |
1,006
-1,116
| -53% | -$295K | ﹤0.01% | 1106 |
|
|
2021
Q2 | $537K | Sell |
2,122
-159
| -7% | -$39.9K | ﹤0.01% | 706 |
|
|
2021
Q1 | $533K | Sell |
2,281
-44
| -2% | -$9.81K | ﹤0.01% | 929 |
|
|
2020
Q4 | $494K | Buy |
+2,325
| New | +$480K | ﹤0.01% | 898 |
|
|
2020
Q1 | – | Sell |
-10,501
| Closed | -$1.43M | – | 819 |
|
|
2019
Q4 | $1.43M | Buy |
10,501
+8,339
| +386% | +$1.05M | 0.01% | 606 |
|
|
2019
Q3 | $237K | Sell |
2,162
-25,732
| -92% | -$3.33M | ﹤0.01% | 762 |
|
|
2019
Q2 | $3.99M | Sell |
27,894
-7,989
| -22% | -$1.09M | 0.03% | 365 |
|
|
2019
Q1 | $4.96M | Buy |
+35,883
| New | +$4.85M | 0.03% | 383 |
|
|
2018
Q2 | – | Sell |
-3,599
| Closed | -$292K | – | 957 |
|
|
2018
Q1 | $292K | Sell |
3,599
-46
| -1% | -$3.7K | ﹤0.01% | 753 |
|
|
2017
Q4 | $279K | Sell |
3,645
-4,813
| -57% | -$347K | ﹤0.01% | 701 |
|
|
2017
Q3 | $582K | Buy |
8,458
+5,192
| +159% | +$338K | 0.01% | 632 |
|
|
2017
Q2 | $226K | Buy |
+3,266
| New | +$200K | ﹤0.01% | 727 |
|
Other funds holding MOH
LIM
Natixis's MOH Position: Q2 2026 in Review
Natixis opened a new position in Molina Healthcare (MOH) in Q2 2026: 61,715 shares worth $14.1M. The stake represents 0.06% of the portfolio and ranks #229 among its holdings. This is a return to the name: Natixis previously reported a position in MOH as recently as Q4 2025.
Natixis first reported a position in MOH in Q2 2017 and has held it in 27 quarters since. The position peaked at $24.1M in Q4 2025. 599 funds tracked by Wall St. Rank hold MOH as of Q2 2026.
- Natixis held 61,715 shares of Molina Healthcare worth $14.1M as of Q2 2026.
- Molina Healthcare was a new Natixis position in Q2 2026.
- Molina Healthcare made up 0.06% of Natixis's portfolio in Q2 2026, its #229 holding.
- Natixis first reported a position in Molina Healthcare in Q2 2017 and has held it in 27 quarters since.
- Natixis's Molina Healthcare position peaked at $24.1M in Q4 2025.
- 599 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.
Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.